Please enable JavaScript to continue using this application.

Compare $ARTV vs $SRZN | Chartloom

Compare

$ARTV vs $SRZN

Artiva Biotherapeutics Inc · Surrozen Inc

ARTV

Artiva Biotherapeutics Inc

SRZN

Surrozen Inc

Compare $ARTV vs $SRZN

Comparing Artiva Biotherapeutics Inc and Surrozen Inc

ARTVArtiva Biotherapeutics Inc

SRZNSurrozen Inc

ARTVArtiva Biotherapeutics Inc

Market cap

$337M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

64.1%

52W performance

131.3%

FCF yield

-22.8%

SRZNSurrozen Inc

Market cap

$345M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

118.58x

Rev growth (TTM)

-8.8%

YTD performance

37.8%

52W performance

111.5%

FCF yield

-10.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARTV

SRZN

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

SRZN

Surrozen Inc

Market Cap

ARTV$337M

SRZN$345M

Enterprise Value

ARTV$36M

SRZN$243M

Price

ARTV$6.94

SRZN$29.69

P/E Ratio

ARTVN/A

SRZNN/A

P/S Ratio

ARTV0.00x

SRZN29.95x

EV/Sales

ARTV0.00x

SRZN21.08x

EV/EBITDA

ARTV0.00x

SRZN0.00x

P/B Ratio

ARTV0.96x

SRZN7.31x

P/FCF Ratio

ARTVN/A

SRZNN/A

EV/FCF

ARTV-0.46x

SRZN-6.94x

PEG Ratio

ARTVN/A

SRZNN/A

Forward P/E (NTM)

ARTVN/A

SRZNN/A

Forward P/S (NTM)

ARTVN/A

SRZN118.58x

Revenue (TTM)

ARTV$0

SRZN$12M

Revenue Growth (YoY)

ARTVN/A

SRZN-8.8%

Forward Rev Growth

ARTV404.4%

SRZN-82.6%

Gross Margin (TTM)

ARTV0.0%

SRZN0.0%

Operating Margin (TTM)

ARTV0.0%

SRZN0.0%

EBITDA Margin (TTM)

ARTV0.0%

SRZN-383.4%

Net Margin (TTM)

ARTV0.0%

SRZN-2885.3%

FCF Margin (TTM)

ARTVN/A

SRZN-303.9%

Net Income (TTM)

ARTV$-42M

SRZN$-332M

FCF (TTM)

ARTV$-77M

SRZN$-35M

EPS (TTM)

ARTV$0.00

SRZN-$28.48

ROE (TTM)

ARTV-6022.0%

SRZN58.2%

ROA (TTM)

ARTV-5238.0%

SRZN-30962.0%

ROIC (TTM)

ARTV-6019.0%

SRZN58.2%

Cash

ARTV$301M

SRZN$102M

Debt

ARTV$0

SRZN$0

Net Cash/Debt

ARTV$301M

SRZN$102M

Current Ratio (TTM)

ARTV24.16x

SRZN12.14x

Quick Ratio (TTM)

ARTV23.97x

SRZN11.88x

Debt/Equity (TTM)

ARTV0.00x

SRZN0.00x

Debt/Assets (TTM)

ARTV0.0%

SRZN0.0%

Interest Coverage (TTM)

ARTVN/A

SRZNN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

SRZN0.00x

Beta

ARTV5.80

SRZN0.53

52W Performance

ARTV131.3%

SRZN111.5%

YTD Performance

ARTV64.1%

SRZN37.8%

% from 52W High

ARTV-52.2%

SRZN-21.5%

% from 52W Low

ARTV156.1%

SRZN160.7%

Asset Turnover (TTM)

ARTV0.00x

SRZN0.11x

FCF Yield (TTM)

ARTV-22.8%

SRZN-10.1%

Earnings Yield (TTM)

ARTV-12.5%

SRZN-96.4%

Dividend Yield (TTM)

ARTVN/A

SRZNN/A

Rule of 40

ARTV0.0

SRZN-312.7

EV/GP/RG

ARTVN/A

SRZNN/A

Ticker research

View ARTV research View SRZN research

Metric	ARTV Artiva Biotherapeutics Inc	SRZN Surrozen Inc
Market & Valuation
Market Cap	$337M	$345M
Enterprise Value	$36M	$243M
Price	$6.94	$29.69
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	29.95x
EV/Sales	0.00x	21.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	7.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	118.58x
Revenue & Growth
Revenue (TTM)	$0	$12M
Revenue Growth (YoY)	N/A	-8.8%
Forward Rev Growth	404.4%	-82.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-383.4%
Net Margin (TTM)	0.0%	-2885.3%
FCF Margin (TTM)	N/A	-303.9%
Net Income (TTM)	$-42M	$-332M
FCF (TTM)	$-77M	$-35M
EPS (TTM)	$0.00	-$28.48
ROE (TTM)	-6022.0%	58.2%
ROA (TTM)	-5238.0%	-30962.0%
ROIC (TTM)	-6019.0%	58.2%
Financial Health
Cash	$301M	$102M
Debt	$0	$0
Net Cash/Debt	$301M	$102M
Current Ratio (TTM)	24.16x	12.14x
Quick Ratio (TTM)	23.97x	11.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	0.53
52W Performance	131.3%	111.5%
YTD Performance	64.1%	37.8%
% from 52W High	-52.2%	-21.5%
% from 52W Low	156.1%	160.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-22.8%	-10.1%
Earnings Yield (TTM)	-12.5%	-96.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-312.7
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View SRZN research

Valuation

P/S Ratio

ARTV

0.00x

SRZN

29.95x

EV/FCF

SRZN

-6.94x

ARTV

-0.46x

Growth & revenue

Revenue Growth TTM

SRZN

-8.8%

Forward Revenue Growth

ARTV

404.4%

SRZN

-82.6%

Profitability & performance

Gross Margin

ARTV

0.0%

SRZN

0.0%

ROE

SRZN

58.2%

ARTV

-6022.0%

FCF Yield %

SRZN

-10.1%

ARTV

-22.8%

52-Week Performance

ARTV

131.3%

SRZN

111.5%

Detailed metrics comparison

ARTV

Artiva Biotherapeutics Inc

SRZN

Surrozen Inc

Market Cap

ARTV$337M

SRZN$345M

Enterprise Value

ARTV$36M

SRZN$243M

Price

ARTV$6.94

SRZN$29.69

P/E Ratio

ARTVN/A

SRZNN/A

P/S Ratio

ARTV0.00x

SRZN29.95x

EV/Sales

ARTV0.00x

SRZN21.08x

EV/EBITDA

ARTV0.00x

SRZN0.00x

P/B Ratio

ARTV0.96x

SRZN7.31x

P/FCF Ratio

ARTVN/A

SRZNN/A

EV/FCF

ARTV-0.46x

SRZN-6.94x

PEG Ratio

ARTVN/A

SRZNN/A

Forward P/E (NTM)

ARTVN/A

SRZNN/A

Forward P/S (NTM)

ARTVN/A

SRZN118.58x

Revenue (TTM)

ARTV$0

SRZN$12M

Revenue Growth (YoY)

ARTVN/A

SRZN-8.8%

Forward Rev Growth

ARTV404.4%

SRZN-82.6%

Gross Margin (TTM)

ARTV0.0%

SRZN0.0%

Operating Margin (TTM)

ARTV0.0%

SRZN0.0%

EBITDA Margin (TTM)

ARTV0.0%

SRZN-383.4%

Net Margin (TTM)

ARTV0.0%

SRZN-2885.3%

FCF Margin (TTM)

ARTVN/A

SRZN-303.9%

Net Income (TTM)

ARTV$-42M

SRZN$-332M

FCF (TTM)

ARTV$-77M

SRZN$-35M

EPS (TTM)

ARTV$0.00

SRZN-$28.48

ROE (TTM)

ARTV-6022.0%

SRZN58.2%

ROA (TTM)

ARTV-5238.0%

SRZN-30962.0%

ROIC (TTM)

ARTV-6019.0%

SRZN58.2%

Cash

ARTV$301M

SRZN$102M

Debt

ARTV$0

SRZN$0

Net Cash/Debt

ARTV$301M

SRZN$102M

Current Ratio (TTM)

ARTV24.16x

SRZN12.14x

Quick Ratio (TTM)

ARTV23.97x

SRZN11.88x

Debt/Equity (TTM)

ARTV0.00x

SRZN0.00x

Debt/Assets (TTM)

ARTV0.0%

SRZN0.0%

Interest Coverage (TTM)

ARTVN/A

SRZNN/A

Net Debt/EBITDA (TTM)

ARTV0.00x

SRZN0.00x

Beta

ARTV5.80

SRZN0.53

52W Performance

ARTV131.3%

SRZN111.5%

YTD Performance

ARTV64.1%

SRZN37.8%

% from 52W High

ARTV-52.2%

SRZN-21.5%

% from 52W Low

ARTV156.1%

SRZN160.7%

Asset Turnover (TTM)

ARTV0.00x

SRZN0.11x

FCF Yield (TTM)

ARTV-22.8%

SRZN-10.1%

Earnings Yield (TTM)

ARTV-12.5%

SRZN-96.4%

Dividend Yield (TTM)

ARTVN/A

SRZNN/A

Rule of 40

ARTV0.0

SRZN-312.7

EV/GP/RG

ARTVN/A

SRZNN/A

Ticker research

View ARTV research View SRZN research

Metric	ARTV Artiva Biotherapeutics Inc	SRZN Surrozen Inc
Market & Valuation
Market Cap	$337M	$345M
Enterprise Value	$36M	$243M
Price	$6.94	$29.69
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	29.95x
EV/Sales	0.00x	21.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.96x	7.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.46x	-6.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	118.58x
Revenue & Growth
Revenue (TTM)	$0	$12M
Revenue Growth (YoY)	N/A	-8.8%
Forward Rev Growth	404.4%	-82.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-383.4%
Net Margin (TTM)	0.0%	-2885.3%
FCF Margin (TTM)	N/A	-303.9%
Net Income (TTM)	$-42M	$-332M
FCF (TTM)	$-77M	$-35M
EPS (TTM)	$0.00	-$28.48
ROE (TTM)	-6022.0%	58.2%
ROA (TTM)	-5238.0%	-30962.0%
ROIC (TTM)	-6019.0%	58.2%
Financial Health
Cash	$301M	$102M
Debt	$0	$0
Net Cash/Debt	$301M	$102M
Current Ratio (TTM)	24.16x	12.14x
Quick Ratio (TTM)	23.97x	11.88x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	5.80	0.53
52W Performance	131.3%	111.5%
YTD Performance	64.1%	37.8%
% from 52W High	-52.2%	-21.5%
% from 52W Low	156.1%	160.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-22.8%	-10.1%
Earnings Yield (TTM)	-12.5%	-96.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-312.7
EV/GP/RG	N/A	N/A
Ticker research	View ARTV research	View SRZN research